The Mount Sinai Division of Liver Disease is established under the leadership of Hans Popper, MD, widely considered the founding father of modern hepatology.

Hans Popper, MD, becomes the Mount Sinai School of Medicine’s first Dean of Academic Affairs. Fenton Schaffner, MD, becomes the inaugural Chief of the Division of Liver Diseases.

Mount Sinai’s Emanuel Rubin, MD, and Charles S. Lieber, MD, demonstrate that alcohol is toxic to the liver in baboons.

In partnership with the Recanati/Miller Transplantation Institute, in 1988, the Division is the first to perform a liver transplantation in New York State.

The Liver Cancer Program is launched under the direction of Josep Llovet, MD, PhD.

The Transplant Hepatology Fellowship at The Mount Sinai Hospital is the first of its kind to be approved by the Accreditation Council for Graduate Medical Education (ACGME) in the Northeast.

The Hepatitis Outreach Network is started by Douglas T. Dieterich, MD, and begins serving communities around New York City.

The Bansal Lab discovers and publishes an article on functional CXCR4 on hepatic stellate cells and implications for liver fibrosis in persons living with HIV.

Konstantina Alexandropoulos, PhD, and Anthony Bonito, PhD, publish an article on their joint study that reveals a mechanism responsible for the development of autoimmune hepatitis.

For the first time, a study led by Matthew Evans, PhD, and Valerie Gouon-Evans, PhD, PharmD, shows that hepatitis C virus can replicate in monkeys.

Josep Llovet, MD, PhD, and Yujin Hoshida, MD, PhD, develop the first gene test used to identify patients with cirrhosis who are at the highest risk of developing the most common type of liver cancer.

The Liver Education and Action Program (LEAP, formerly INSPIRE) is launched as a patient coordination program to serve those with viral hepatitis.

The Branch Lab is awarded a World Trade Center grant to study liver diseases in first responders.

Tatyana Kushner, MD, MSCE, launches the first Women’s Liver Clinic.

Under the direction of Meena B. Bansal, MD, Mount Sinai Health System establishes the MASLD/MASH Program and Center of Excellence. 

Augusto Villanueva Rodriguez, MD, PhD, is awarded a U01 grant from the National Institutes of Health to study the early biomarkers of liver cancer.

Meena B. Bansal, MD, is named System Chief of the Division of Liver Diseases.

Under the leadership of Scott L. Friedman, MD, the Institute for Liver Research at Icahn Mount Sinai is launched.